Fort Lee, New Jersey, USA, March 12, 2015 (GLOBE NEWSWIRE) -- Herborium® Group,
Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical
Therapeutics® Company and provider of unique, all
botanical medicines (Botanical Therapeutics®), will
deploy new partnerships to develop a product line extension and tap
into new profitable markets for its unique, all herbal acne
treatment, AcnEase®. The new topical, all
natural product is to be introduced in 2015 and is a highly
desirable addition to AcnEase Skin Management
System® In addition to meeting customers demand
this new, complementary acne product will support a further
exponential growth of the brand and add to the Company's bottom
line as it benefits from AcnEase® brand
recognition, customer base and existing sales infrastructure.
In addition, the new global and domestic
partnerships that are developed around the product extension
include co-marketing arrangements, allowing
AcnEase® branded products to enter new, large
markets including those in Asia.
AcnEase
®, www.acnease.com, that is
differentiated by its clinically validated efficacy and
unprecedented safety profile, has up to 96% success rate in
treating acne. The product targets over 750 million acne
sufferers in the United States and Canada, over 80 million people
with acne in Europe, and now 200 million acne sufferers in
Asia. 75% of all people will have acne at in the certain times of
their lives
AcnEase is especially effective in hard
treatable cases of adult hormonal acne in women and men that is
becoming more prevailing... Average age of acne sufferer in the US
has increased from 21.5 to 26.5 in the last decade. After a
withdrawal of Accutane (Roche Pharmaceuticals) from the market due
to safety concerns and Class Action Suite, this dramatically
growing and health conscious market was left without an effective
treatment. AcnEase® is an all-natural and
highly effective and safe treatment for adult and teen acne that is
gaining enthusiastic reviews from users. The total global
market for acne treatment is over $4 billion, with the spending on
skin conditions growing at a rate of over 11 percent per year.
Due to environmental conditions and social demand, more and
more individuals seek specialty treatment of acne and related skin
conditions.
"We are very excited about the prospect of our
product line extension and, new global and domestic partners
joining us in building the AcnEase® brand
throughout the world. This is a large step forwards to
continue the exponential growth of Herborium as a global company,
to provide valuable Botanical Therapeutics®to
an increasing number of consumers and distributors, and to increase
shareholders value" commented Dr. Agnes P. Olszewski, CEO and
Chairwoman of Herborium.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics®
company that develops, license and markets proprietary, botanical
based medicinal products to consumers and healthcare professionals.
The Company business model focuses on emerging market opportunities
spearheaded by the growth of a new market sector located between
high-cost, high-risk, ethical pharmaceuticals and commoditized
classic nutraceuticals (supplements). The Company uses
clinical validation and a proactive regulatory strategy based on
the FDA Guidance for Industry: Botanical Drug Products
(FDA Guidance 2004) to establish and maintain a
differential advantage. Herborium has secured a pipeline of
botanical ingredients based products in the areas of dermatological
needs, wellness and energy, prostate health, women's health and
selected sexual disorders resulting from cardiovascular disease,
use of anti-depressants, diabetes, surgical procedures, and other
problems. Herborium Group sells its products in the United States,
the United Kingdom, and continental Europe through a network of
distributors, specialty retailers, and e-commerce. For more
information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release
contains forward-looking statements with respect to the results of
operations and business of Herborium Group, Inc., which involves
risks and uncertainties. The Company's actual future results
could materially differ from those discussed. The Company
intends that such statements about the Company's future
expectations, including future revenues and earnings, and all other
forward looking statements be subject to the "Safe Harbors"
provision of the Private Securities Litigation Reform Act of
1995.
CONTACT: Herborium Group, Inc.
Email: InvestorsRelations@Herborium.com